ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

4.39
Delayed Data
As of 4:00pm ET
 +0.05 / +1.15%
Today’s Change
3.33
Today|||52-Week Range
7.12
+6.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.4M4.3M6.9M6.4M
 
 
 
 
 
Depreciation And Amortization462.0K357.0K290.0K369.0K
 
 
 
 
 
 
Operating ExpensesGross Income911.0K------
 
 
General Expenses44.4M114.1M171.9M59.5M
 
 
 
 
 
Research And Development32.7M96.8M157.8M45.1M
 
 
 
 
 
Total Operating Expenses44.9M114.4M172.2M59.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-43.5M-110.1M-165.3M-53.5M
 
 
 
 
 
Extraordinary Credit11.7M0.000.000.00
 
 
Extraordinary Charge0.00-10.0M-124.0K-1.3M
 
 
 
 
Other Expenses-5.0K12.0K134.0K465.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.8M-120.1M-165.3M-54.3M
 
 
 
 
 
Preferred Dividend0.000.00-7.1M-18.9M
 
 
 
Net Income-31.8M-120.1M-165.3M-54.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS101.1M125.4M130.4M136.9M
 
 
 
 
 
Shares To Calculate EPS Diluted101.1M125.4M130.4M136.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.96-$1.32-$0.53
 
 
 
 
 
EPS Diluted-$0.31-$0.96-$1.32-$0.53